NIFTY PHARMA
Active threads
Tencent-backed Enflame IPO draws 6,109 times online demand
2 Min Read Chinese AI chipmaker Shanghai Enflame Technology, backed by Tencent, drew investor orders worth 6,109 times the shares available in the online portion of its Shanghai initial public offering, an exchange filing showed on Wednesday.
Noumed Renews AUD 30M Pharmacy Supply Deal, Boosts OTC Book
Noumed Pharmaceuticals has renewed its supply agreement with a leading Australian pharmacy chain, securing a AUD 30 million deal. This second contract renewal has pushed Sai Parenterals' Australian OTC supply book to ₹1,506 crore, indicating strong ongoing demand for its products in the Australian market.
Galaxy Surfactants Q1 profit doubles, shares hit upper circuit
Galaxy Surfactants reported a 109% year-on-year jump in Q1 profit to Rs 166 crore, driving shares to a 20% upper circuit. The strong earnings beat has sparked a sharp rally, with the stock hitting its daily limit on two consecutive trading sessions.
Adline Chem Lab swings to Rs 0.04 crore profit
Adline Chem Lab reports standalone net profit of Rs 0.04 crore in the June 2026 quarter Reported sales nil Net profit of Adline Chem Lab reported to Rs 0.04 crore in the quarter ended June 2026 as against net loss of Rs 0.05 crore during the previous quarter ended June 2025.
PI Industries plunges 10% to 52-week low on weak Q1
PI Industries shares tumbled 10% to hit a 52-week low after reporting disappointing Q1 results that missed analyst estimates. The sharp selloff reflects investor concerns over the company's near-term earnings outlook and margin pressure. Both articles confirm the magnitude of the decline and the negative market reaction.
Intelligence feed
No articles in the last 24 hours.